Status: Recruiting
Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases
The Occlutech® mVSD is indicated for percutaneous occlusion of hemodynamically or clinically significant muscular ventricular septal defects. The objectives of the study are: * To confirm the efficacy of Occlutech mVSD in patients requiring transcatheter occlusion (closure) of muscular ventricular septal defects. * To confirm the safety of Occlutech mVSD in patients requiring transcatheter occlusion (closure) of muscular ventricular septal defects.
Participants needed: 50
Trial details
Age: 3-80Biological sex: AllType: ObservationalSponsor: Occlutech International ABUpdated: Feb 2, 2026Locations: 5Duration: 3 Years
Eligibility criteria
A participant will be eligible for study participation if he/she meets the indic... [+11]
Active infection at the time of implantation [+11]